Effects of Health Insurance Interruption on Loss of Hypertension Control in Women with and Women Without HIV

Andrew Edmonds, Christina Ludema, Joseph J. Eron, Stephen R. Cole, Adebola A. Adedimeji, Mardge H. Cohen, Hannah L. Cooper, Margaret Fischl, Mallory O. Johnson, Denise D. Krause, Dan Merenstein, Joel Milam, Tracey E. Wilson, Adaora A. Adimora

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Among low-income women with and without HIV, it is a priority to reduce age-related comorbidities, including hypertension and its sequelae. Because consistent health insurance access has been identified as an important factor in controlling many chronic diseases, we estimated the effects of coverage interruption on loss of hypertension control in a cohort of women in the United States. Methods: We analyzed prospective, longitudinal data from the Women's Interagency HIV Study. HIV-infected and HIV-uninfected women were included between 2005 and 2014 when they reported health insurance at consecutive biannual visits and had controlled hypertension, and were followed for any insurance break and loss of hypertension control. We estimated hazard ratios (HRs) by Cox proportional hazards regression with inverse-probability-of-treatment-and censoring weights (marginal structural models), and plotted the cumulative incidence of hypertension control loss. Results: Among 890 HIV-infected women, the weighted HR for hypertension control loss comparing health insurance interruption to uninterrupted coverage was 1.37 (95% confidence interval [CI], 0.99-1.91). Inclusion of AIDS Drug Assistance Program (ADAP) participation with health insurance modestly increased the HR (1.47; 95% CI, 1.04-2.07). Analysis of 272 HIV-uninfected women yielded a similar HR (1.39; 95% CI, 0.88-2.21). Additionally, there were indications of uninterrupted coverage having a protective effect on hypertension when compared with the natural course in HIV-infected (HR, 0.82; 95% CI, 0.61-1.11) and HIV-uninfected (HR, 0.78; 95% CI, 0.52-1.19) women. Conclusions: This study provides evidence that health insurance continuity promotes hypertension control in key populations. Interventions that ensure coverage stability and ADAP access should be a policy priority.

Original languageEnglish (US)
Pages (from-to)1292-1301
Number of pages10
JournalJournal of Women's Health
Volume26
Issue number12
DOIs
StatePublished - Dec 1 2017

Fingerprint

Health Insurance
HIV
Hypertension
Confidence Intervals
Anti-HIV Agents
Structural Models
Insurance
Comorbidity
Chronic Disease
Weights and Measures
Incidence
Population

Keywords

  • health insurance
  • HIV/AIDS
  • hypertension
  • women

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Effects of Health Insurance Interruption on Loss of Hypertension Control in Women with and Women Without HIV. / Edmonds, Andrew; Ludema, Christina; Eron, Joseph J.; Cole, Stephen R.; Adedimeji, Adebola A.; Cohen, Mardge H.; Cooper, Hannah L.; Fischl, Margaret; Johnson, Mallory O.; Krause, Denise D.; Merenstein, Dan; Milam, Joel; Wilson, Tracey E.; Adimora, Adaora A.

In: Journal of Women's Health, Vol. 26, No. 12, 01.12.2017, p. 1292-1301.

Research output: Contribution to journalArticle

Edmonds, A, Ludema, C, Eron, JJ, Cole, SR, Adedimeji, AA, Cohen, MH, Cooper, HL, Fischl, M, Johnson, MO, Krause, DD, Merenstein, D, Milam, J, Wilson, TE & Adimora, AA 2017, 'Effects of Health Insurance Interruption on Loss of Hypertension Control in Women with and Women Without HIV', Journal of Women's Health, vol. 26, no. 12, pp. 1292-1301. https://doi.org/10.1089/jwh.2016.6308
Edmonds, Andrew ; Ludema, Christina ; Eron, Joseph J. ; Cole, Stephen R. ; Adedimeji, Adebola A. ; Cohen, Mardge H. ; Cooper, Hannah L. ; Fischl, Margaret ; Johnson, Mallory O. ; Krause, Denise D. ; Merenstein, Dan ; Milam, Joel ; Wilson, Tracey E. ; Adimora, Adaora A. / Effects of Health Insurance Interruption on Loss of Hypertension Control in Women with and Women Without HIV. In: Journal of Women's Health. 2017 ; Vol. 26, No. 12. pp. 1292-1301.
@article{3385803b0d554202a7bf0c8ef9bf4156,
title = "Effects of Health Insurance Interruption on Loss of Hypertension Control in Women with and Women Without HIV",
abstract = "Background: Among low-income women with and without HIV, it is a priority to reduce age-related comorbidities, including hypertension and its sequelae. Because consistent health insurance access has been identified as an important factor in controlling many chronic diseases, we estimated the effects of coverage interruption on loss of hypertension control in a cohort of women in the United States. Methods: We analyzed prospective, longitudinal data from the Women's Interagency HIV Study. HIV-infected and HIV-uninfected women were included between 2005 and 2014 when they reported health insurance at consecutive biannual visits and had controlled hypertension, and were followed for any insurance break and loss of hypertension control. We estimated hazard ratios (HRs) by Cox proportional hazards regression with inverse-probability-of-treatment-and censoring weights (marginal structural models), and plotted the cumulative incidence of hypertension control loss. Results: Among 890 HIV-infected women, the weighted HR for hypertension control loss comparing health insurance interruption to uninterrupted coverage was 1.37 (95{\%} confidence interval [CI], 0.99-1.91). Inclusion of AIDS Drug Assistance Program (ADAP) participation with health insurance modestly increased the HR (1.47; 95{\%} CI, 1.04-2.07). Analysis of 272 HIV-uninfected women yielded a similar HR (1.39; 95{\%} CI, 0.88-2.21). Additionally, there were indications of uninterrupted coverage having a protective effect on hypertension when compared with the natural course in HIV-infected (HR, 0.82; 95{\%} CI, 0.61-1.11) and HIV-uninfected (HR, 0.78; 95{\%} CI, 0.52-1.19) women. Conclusions: This study provides evidence that health insurance continuity promotes hypertension control in key populations. Interventions that ensure coverage stability and ADAP access should be a policy priority.",
keywords = "health insurance, HIV/AIDS, hypertension, women",
author = "Andrew Edmonds and Christina Ludema and Eron, {Joseph J.} and Cole, {Stephen R.} and Adedimeji, {Adebola A.} and Cohen, {Mardge H.} and Cooper, {Hannah L.} and Margaret Fischl and Johnson, {Mallory O.} and Krause, {Denise D.} and Dan Merenstein and Joel Milam and Wilson, {Tracey E.} and Adimora, {Adaora A.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1089/jwh.2016.6308",
language = "English (US)",
volume = "26",
pages = "1292--1301",
journal = "Journal of Women's Health",
issn = "1540-9996",
publisher = "Mary Ann Liebert Inc.",
number = "12",

}

TY - JOUR

T1 - Effects of Health Insurance Interruption on Loss of Hypertension Control in Women with and Women Without HIV

AU - Edmonds, Andrew

AU - Ludema, Christina

AU - Eron, Joseph J.

AU - Cole, Stephen R.

AU - Adedimeji, Adebola A.

AU - Cohen, Mardge H.

AU - Cooper, Hannah L.

AU - Fischl, Margaret

AU - Johnson, Mallory O.

AU - Krause, Denise D.

AU - Merenstein, Dan

AU - Milam, Joel

AU - Wilson, Tracey E.

AU - Adimora, Adaora A.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Background: Among low-income women with and without HIV, it is a priority to reduce age-related comorbidities, including hypertension and its sequelae. Because consistent health insurance access has been identified as an important factor in controlling many chronic diseases, we estimated the effects of coverage interruption on loss of hypertension control in a cohort of women in the United States. Methods: We analyzed prospective, longitudinal data from the Women's Interagency HIV Study. HIV-infected and HIV-uninfected women were included between 2005 and 2014 when they reported health insurance at consecutive biannual visits and had controlled hypertension, and were followed for any insurance break and loss of hypertension control. We estimated hazard ratios (HRs) by Cox proportional hazards regression with inverse-probability-of-treatment-and censoring weights (marginal structural models), and plotted the cumulative incidence of hypertension control loss. Results: Among 890 HIV-infected women, the weighted HR for hypertension control loss comparing health insurance interruption to uninterrupted coverage was 1.37 (95% confidence interval [CI], 0.99-1.91). Inclusion of AIDS Drug Assistance Program (ADAP) participation with health insurance modestly increased the HR (1.47; 95% CI, 1.04-2.07). Analysis of 272 HIV-uninfected women yielded a similar HR (1.39; 95% CI, 0.88-2.21). Additionally, there were indications of uninterrupted coverage having a protective effect on hypertension when compared with the natural course in HIV-infected (HR, 0.82; 95% CI, 0.61-1.11) and HIV-uninfected (HR, 0.78; 95% CI, 0.52-1.19) women. Conclusions: This study provides evidence that health insurance continuity promotes hypertension control in key populations. Interventions that ensure coverage stability and ADAP access should be a policy priority.

AB - Background: Among low-income women with and without HIV, it is a priority to reduce age-related comorbidities, including hypertension and its sequelae. Because consistent health insurance access has been identified as an important factor in controlling many chronic diseases, we estimated the effects of coverage interruption on loss of hypertension control in a cohort of women in the United States. Methods: We analyzed prospective, longitudinal data from the Women's Interagency HIV Study. HIV-infected and HIV-uninfected women were included between 2005 and 2014 when they reported health insurance at consecutive biannual visits and had controlled hypertension, and were followed for any insurance break and loss of hypertension control. We estimated hazard ratios (HRs) by Cox proportional hazards regression with inverse-probability-of-treatment-and censoring weights (marginal structural models), and plotted the cumulative incidence of hypertension control loss. Results: Among 890 HIV-infected women, the weighted HR for hypertension control loss comparing health insurance interruption to uninterrupted coverage was 1.37 (95% confidence interval [CI], 0.99-1.91). Inclusion of AIDS Drug Assistance Program (ADAP) participation with health insurance modestly increased the HR (1.47; 95% CI, 1.04-2.07). Analysis of 272 HIV-uninfected women yielded a similar HR (1.39; 95% CI, 0.88-2.21). Additionally, there were indications of uninterrupted coverage having a protective effect on hypertension when compared with the natural course in HIV-infected (HR, 0.82; 95% CI, 0.61-1.11) and HIV-uninfected (HR, 0.78; 95% CI, 0.52-1.19) women. Conclusions: This study provides evidence that health insurance continuity promotes hypertension control in key populations. Interventions that ensure coverage stability and ADAP access should be a policy priority.

KW - health insurance

KW - HIV/AIDS

KW - hypertension

KW - women

UR - http://www.scopus.com/inward/record.url?scp=85038420335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038420335&partnerID=8YFLogxK

U2 - 10.1089/jwh.2016.6308

DO - 10.1089/jwh.2016.6308

M3 - Article

C2 - 28682658

AN - SCOPUS:85038420335

VL - 26

SP - 1292

EP - 1301

JO - Journal of Women's Health

JF - Journal of Women's Health

SN - 1540-9996

IS - 12

ER -